ATE340793T1 - Neue synthese von irbesartan - Google Patents

Neue synthese von irbesartan

Info

Publication number
ATE340793T1
ATE340793T1 AT03764805T AT03764805T ATE340793T1 AT E340793 T1 ATE340793 T1 AT E340793T1 AT 03764805 T AT03764805 T AT 03764805T AT 03764805 T AT03764805 T AT 03764805T AT E340793 T1 ATE340793 T1 AT E340793T1
Authority
AT
Austria
Prior art keywords
irbesartan
new synthesis
synthesis
employing
particle size
Prior art date
Application number
AT03764805T
Other languages
English (en)
Inventor
Gennady Nisnevich
Igor Rukhman
Boris Pertsikov
Julia Kaftanov
Ben-Zion Dolitzky
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE340793T1 publication Critical patent/ATE340793T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03764805T 2002-07-16 2003-07-16 Neue synthese von irbesartan ATE340793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39642402P 2002-07-16 2002-07-16
US40249002P 2002-08-09 2002-08-09

Publications (1)

Publication Number Publication Date
ATE340793T1 true ATE340793T1 (de) 2006-10-15

Family

ID=30118586

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03764805T ATE340793T1 (de) 2002-07-16 2003-07-16 Neue synthese von irbesartan

Country Status (11)

Country Link
US (1) US20050176794A1 (de)
EP (1) EP1546135B1 (de)
CN (1) CN1668612A (de)
AT (1) ATE340793T1 (de)
AU (1) AU2003256609A1 (de)
CA (1) CA2492779A1 (de)
DE (1) DE60308708T2 (de)
ES (1) ES2273041T3 (de)
IL (1) IL166306A0 (de)
PT (1) PT1546135E (de)
WO (1) WO2004007482A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004065383A2 (en) 2003-01-16 2004-08-05 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
DE602004015071D1 (de) * 2003-02-05 2008-08-28 Teva Pharma Synthese von 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro-4,4 -nonen-4-on
GB2419592A (en) * 2004-10-26 2006-05-03 Cipla Ltd Process for the preparation of irbesartan hydrochloride
SI21965A (sl) * 2005-01-05 2006-08-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava tetrazolskega derivata
WO2006097121A1 (en) * 2005-03-16 2006-09-21 Ulkar Kimya Sanayii Ve Ticaret A.S. Method for producing biphenyl-tetrazole compounds
WO2006136916A2 (en) * 2005-06-20 2006-12-28 Glenmark Pharmaceuticals Limited Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
US7964737B2 (en) 2005-07-27 2011-06-21 Jubilant Organosys Limited Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4] non-1-en-4-one
EP1749828A1 (de) 2005-08-04 2007-02-07 Farmaprojects S.L. Verfahren zur Herstellung eines Angiotensin-II-Antagonisten
EP1806130B1 (de) 2006-01-09 2010-03-31 KRKA, D.D., Novo Mesto Irbesartan enthaltende feste Zubereitung
WO2007115990A1 (en) * 2006-04-07 2007-10-18 Lek Pharmaceuticals D.D. Process for the preparation of pure irbesartan
JP2009515834A (ja) * 2006-08-29 2009-04-16 テバ ファーマシューティカル インダストリーズ リミティド ５−フェニル−１−トリチル−１ｈ−テトラゾールの合成のための方法
CN100413853C (zh) * 2006-09-21 2008-08-27 浙江海正药业股份有限公司 厄贝沙坦的合成中间体及其制备方法和制备药物的用途
RU2495040C1 (ru) * 2012-05-03 2013-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Чувашский государственный университет имени И.Н. Ульянова" Способ получения 3-амино-8-гидрокси-1,6-диоксо-2,7-диазаспиро[4.4]нон-3-ен-4-карбонитрилов
CN102875534B (zh) * 2012-09-10 2015-05-27 珠海保税区丽珠合成制药有限公司 一种厄贝沙坦的合成方法
CN105001209A (zh) * 2015-06-29 2015-10-28 千辉药业（安徽）有限责任公司 一种厄贝沙坦的合成方法
CN108218841A (zh) * 2018-03-06 2018-06-29 大桐制药（中国）有限责任公司 一种高纯度抗高血压药物依贝沙坦的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
FR2725987B1 (fr) * 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst

Also Published As

Publication number Publication date
AU2003256609A1 (en) 2004-02-02
CN1668612A (zh) 2005-09-14
AU2003256609A8 (en) 2004-02-02
IL166306A0 (en) 2006-01-15
EP1546135A2 (de) 2005-06-29
DE60308708D1 (de) 2006-11-09
US20050176794A1 (en) 2005-08-11
EP1546135B1 (de) 2006-09-27
ES2273041T3 (es) 2007-05-01
PT1546135E (pt) 2006-12-29
WO2004007482A3 (en) 2004-05-27
WO2004007482A2 (en) 2004-01-22
CA2492779A1 (en) 2004-01-22
DE60308708T2 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
ATE340793T1 (de) Neue synthese von irbesartan
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
DE60122528D1 (de) Synthese von molekularsiebkatalysatoren
DK1578733T3 (da) Fremgangsmåde til fremstilling af rosuvastatin
ATE300528T1 (de) Synthese von cannabinoiden
MY136728A (en) Preparation of titania and cobalt aluminate catalyst supports and their use in fischer-tropsch synthesis
NO20060044L (no) Fremgangsmate for fremstilling av substituerte 3-aryl-butyl-aminforbindelser
SE0100903D0 (sv) Compounds
NO20031178L (no) Chemokin-reseptorbindende heterocykliske forbindelser
DE69916582D1 (de) Synthese von zsm-48
ATE398121T1 (de) Neue synthese von irbesartan
EA200300925A1 (ru) Новый способ промышленного синтеза ранелата стронция и его гидратов
NO20042614L (no) Katalysator for metanolsyntesen
DE69912206D1 (de) Verbesserte Synthese von Haloformiminverbindungen
ATE341541T1 (de) Synthese von 3,6-dialkyl-5,6-dihydro-4-hydroxy- pyran-2-one
ATE411287T1 (de) Neue metallproteinaseinhibitoren
NO20021409D0 (no) Hastighets-kontrollerte partikler
ATE402173T1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
EA200500202A1 (ru) Новый способ синтеза (7-метокси-3,4-дигидро-1-нафталинил)ацетонитрила и его применение при синтезе агомелатина
DE60216948D1 (en) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
ATE250584T1 (de) Synthese von 5- oder 8-bromoisoquinolin derivaten
BR0208628A (pt) Processo para produzir compostos de truncamida a
ATE264306T1 (de) Synthese von 3-amino-2-chlor-4-methylpyridin aus malonsäuresäurenitril und aceton
DE60034571D1 (de) Festphasensynthese von n,n-disubstituierten diazacycloalkylcarboxy-derivaten
TR200302026T4 (tr) (2S)-aminoindan türevleri, hazırlanmaları için bir işlem ve seçici dopamin D3 ligandları olarak kullanımları.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties